Big news for our European patients and physicians! AtriClip Left Atrial Appendage Exclusion Systems are now indicated for use in patients at high risk of thromboembolism for whom LAAE is warranted. Deployed in more than 550,000 cases worldwide, we're excited to witness the significant impact our devices are making on patient care.

Read on to learn more: <a href="https://okt.to/KhDyQR&quot; target="_blank">https://okt.to/KhDyQR</a&gt;